2017 Gastrointestinal Cancers Symposium

2017 Gastrointestinal Cancers Symposium

Nivolumab a New Treatment Option for Patients with Advanced Gastric Cancer

Nivolumab as salvage treatment significantly reduced the risk for death after second-line or later chemotherapy in patients with advanced gastric or gastroesophageal junction cancer. In a double-blind, randomized phase 3 [ Read More ]